AVEO Pharmaceuticals, Inc. to Utilize Peptech Limited's Breakthrough Technology to ''Humanise'' Internal Drug Candidates

Published: Oct 02, 2007

CAMBRIDGE, Mass. & SYDNEY, Australia--(BUSINESS WIRE)--Peptech Limited (ASX: PTD) and AVEO Pharmaceuticals Inc. today announced they have entered into a non-exclusive research and commercialisation agreement in which AVEO will access Peptech’s SuperhumanisationTM technology to humanise internally-derived drug candidates.

Back to news